Literature DB >> 192677

Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections.

N J Schmidt, J Dennis, E H Lennette.   

Abstract

Various subunit antigens of varicella-zoster (V-Z) virus were examined for complement-fixing (CF) activity with sera from homotypic infections and from herpes simplex virus (HSV) infections in which a CF antibody titer rise was demonstrated with crude V-Z antigen. The subunit antigens included nucleocapsids, envelopes, a soluble antigen produced from infected culture fluids by sucrose density gradient centrifugation, a soluble antigen produced by reducing the volume of clarified infected culture fluids, a soluble antigen derived from infected cell lysates, a "viral" antigen consisting largely of enveloped particles with a few nucleocapsids, and a cell membrane-associated antigen. None was more suitable than crude V-Z antigen for serodifferentiation of V-Z virus and HSV infections. The envelope antigen, cell membrane antigen, and the soluble antigen prepared by density gradient centrifugation showed little reactivity with sera from varicella and HSV infections, but gave high antibody titers with sera from zoster infections, suggesting that a secondary V-Z virus infection is required to produce an antibody response to these subunit antigens. Patients with varicella and zoster infections and the selected patients with HSV infections all showed significant CF antibody responses to the other V-Z subunit antigens.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192677      PMCID: PMC421451          DOI: 10.1128/iai.15.3.850-854.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  A COMPLEMENT-FIXING ANTIGEN FOR VARICELLA-ZOSTER DERIVED FROM INFECTED CULTURES OF HUMAN FETAL DIPLOID CELLS.

Authors:  N J SCHMIDT; E H LENNETTE; C W SHON; T T SHINOMOTO
Journal:  Proc Soc Exp Biol Med       Date:  1964-05

2.  POSSIBLE ANTIGENIC RELATIONSHIP BETWEEN VARICELLA ZOSTER VIRUS AND HERPES SIMPLEX VIRUS.

Authors:  J G KAPSENBERG
Journal:  Arch Gesamte Virusforsch       Date:  1964-09-09

3.  Complement-fixing antigens produced by varicella-zoster virus in tissue culture.

Authors:  M L Martin; E L Palmer
Journal:  Appl Microbiol       Date:  1973-09

4.  Complement-fixing antigens of herpes simplex virus types 1 and 2: reactivity of capsid, envelope, and soluble antigens.

Authors:  M L Martin; E L Palmer; R E Kissling
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

5.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.

Authors:  N J Schmidt; E H Lennette; R L Magoffin
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

6.  Varicella virus in HeLa cells.

Authors:  A Svedmyr
Journal:  Arch Gesamte Virusforsch       Date:  1965

7.  Solid phase radioimmunoassay for typing herpes simplex viral antibodies in human sera.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  J Clin Microbiol       Date:  1975-11       Impact factor: 5.948

8.  Neutralizing antibody responses to varicella-zoster virus.

Authors:  N J Schmidt; E H Lennette
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

9.  Type specificity of complement-requiring and immunoglobulin M neutralizing antibody in initial herpes simplex virus infections of humans.

Authors:  N J Schmidt; B Forghani; E H Lennette
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

10.  Reactivity of envelope, capsid, and soluble antigens of Herpesvirus hominis types 1 and 2 in the indirect hemagglutination test.

Authors:  A F Back; N J Schmidt
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

  10 in total
  5 in total

1.  Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination.

Authors:  C L Wong; S Castriciano; M A Chernesky; W E Rawls
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

2.  Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.

Authors:  M Takayama
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

3.  Human serum antibodies to varicella-zoster virus thymidine kinase.

Authors:  C F Källander; J S Gronowitz; E G Torfason
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

4.  Rapid diagnosis of varicella-zoster virus infection by detection of viral deoxythymidine kinase in serum and vesicle fluid.

Authors:  C F Källander; J S Gronowitz; E Olding-Stenkvist
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

5.  Differentiation of members of the human herpesviridae family by radioimmunoassay.

Authors:  K O Smith; W Kennell
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.